Deltagen, Inc., and Hyseq, Inc. have announced a major collaboration to undertake the research and development of approximately 200 novel secreted proteins. Under the terms of the agreement, Hyseq will provide gene sequences encoding secreted proteins from their extensive intellectual property portfolio and Deltagen will utilize its proprietary in vivo mammalian gene knockout technology to Read more about Deltagen And Hyseq To Develop Novel Secreted Proteins[…]